This video is sponsored by the Duke Clinical Medical Series.
Topics include:
* Variability in Response to Oral Antiplatelet Agents
* Preventing Complications of Atherosclerosis
* Preventing Complications of Atherosclerosis
* Genetic Variability: Platelet Response to ADP
* Variability in Plt Aggregation (No Tx) & Clinical Outcome
* Genetic Variability: Platelet Response to ADP
* Variability in Plt Aggregation (No Tx) & Clinical Outcome
* Interindividual Variability: ASA Response
* Interpatient Variability in ASA Response: Bleed Time (BT)
* ASA Responsiveness by PFA-100 & Aggregometry
The moderator, Peter Berger, MD, has indicated that he receives research/grant support
from Aventis, Conor, Guilford, Lumen, and Velocimed. Dr. Berger is also a member of an
advisory board for Genentech and Cordis/Johnson & Johnson; he has spoken at scientific
symposia for Aventis, Bristol-Myers Squibb, Genentech, and Guilford. Dr. Berger also
serves as Medical Director and has equity with Lumen, Inc.
The guest faculty, Dr. Steven Steinhubl, has indicated that he received research/grant
support, and is a consultant for, The sanofi-aventis Group and The Medicine's Company.
|
|